Harvard Bioscience Inc.

Holliston, MA Harvard Apparatus

UEI
CS6JFXF1C373
CAGE
1MBG8
Primary NAICS
334516 Analytical Laboratory Instrument Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
Corporate family
SAM.gov registration date
Physical address
84 October Hill Rd, Holliston, MA 01746, USA
Founded
1901
Employees
251-1K
Estimated annual revenue
$100M-$250M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Life Sciences Tools & Services
SIC code
38 Instruments & Related Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $108,801
FY2025 -$220
FY2024 $144,207
FY2023 $1,638

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Department of Health and Human Services $92,215
2 Department of Veterans Affairs $16,586

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Contract subawards

Prime contractor Prime award Amount Awarded
The Johns Hopkins University Applied Physics Laboratory LLC DARPA RESEARCH PROGRAM SUPPORT SERVICES Materials HR001125FE001 $166,504

Grant awards

Award Agency Obligated Awarded
Patch clamp amplifiers on a chip R42NS062408 National Institutes of Health $783,321
Patch clamp amplifiers on a chip R41NS062408 National Institutes of Health $134,245

Similar vendors

About the company

Harvard Bioscience Inc., operating through its Harvard Apparatus Division and subsidiaries, manufactures and sells specialized biomedical research equipment and scientific instruments to federal agencies as a prime contractor, competing predominantly on a full-and-open basis with no set-aside designations. The company is a self-certified small disadvantaged business and for-profit manufacturer of goods headquartered in Holliston, Massachusetts. Harvard Bioscience operates through six named subsidiaries including Hoefer, Inc., Coulbourn Instruments LLC, Denville Scientific Inc., and Triangle Biosystems Inc., each contributing to its portfolio of electrophysiology systems, syringe pumps, ventilators, electroporators, and specialized laboratory instrumentation for in vivo and in vitro research.

Harvard Bioscience's federal work spans 357 awards over the past two decades, concentrated in small-value purchase orders for direct equipment and supplies rather than larger systems integration or service contracts. Recent representative awards include a $92,730 firm fixed-price definitive contract from the Office of Logistics and Acquisition Operations for aging AgilePulse in vivo electroporation systems (September 2026, completion September 2027); a $66,634 firm fixed-price purchase order from the Department of Veterans Affairs Veterans Integrated Service Network 9 for a Harvard Wireless Rodent Electrophysiology System at Nashville VAMC (March 2024); a $25,822 purchase order from the Department of Energy's Office of Fossil Energy for high-pressure syringe pump equipment supporting continuous plasma runs at the National Energy Technology Laboratory in Morgantown, West Virginia (June 2024); and a $22,763 purchase order from the National Institute on Drug Abuse for catalog-based syringe pumps, ventilators, and electrophysiology systems (September 2024). Set-aside activity is minimal: two awards carry Total Small Business designations, while the overwhelming majority are full-and-open procurements.

Customer concentration is broad but tilted toward life-sciences and medical research agencies. The top five customers by award count account for 21 percent of awards, led by the Department of the Army Medical Command (23 awards, $322 thousand combined potential value) and the National Institute on Drug Abuse (17 awards, $104 thousand). By potential value, the ranking shifts: the Food and Drug Administration leads with 11 awards valued at $364 thousand combined, followed by Army Medical Command and Department of Veterans Affairs Veterans Integrated Service Network 7 (6 awards, $261 thousand). The vendor serves 67 distinct federal agencies across health research, biomedical science, energy, and defense research portfolios. Harvard Bioscience's award portfolio concentrates in two primary NAICS categories: Analytical Laboratory Instrument Manufacturing (170 awards) and Surgical and Medical Instrument Manufacturing (20 awards), with corresponding PSC coding emphasizing Laboratory Equipment and Supplies (223 awards) and Medical and Surgical Instruments, Equipment, and Supplies (70 awards).

Activity has been intermittent over recent years: three awards in 2022, one in 2023, five in 2024, one in 2025, and two in 2026. The combined potential value across all 357 awards is $4.2 million, though obligated dollars total $5.5 million—indicating both historical execution and mature contract completion. Only one award reaches recompete in the next twenty-four months (combined potential value $93 thousand), suggesting minimal near-term recompete exposure. Harvard Bioscience maintains a single named subcontract award: a sub position under Johns Hopkins University Applied Physics Laboratory LLC on a DARPA research program support services contract for materials (May 2025). The vendor's prime footprint is entirely federal contracts (356 prime awards, 100 percent of total activity), with no federal grant prime awards or participation in major government-wide vehicles such as GWACs or agency-wide IDIQs beyond a single Indefinite Delivery Contract (HR001122D0001).

Quick answers

Is Harvard Bioscience Inc. registered in SAM.gov?

Yes. Harvard Bioscience Inc.'s SAM.gov registration is active through July 10, 2027.

How much has Harvard Bioscience Inc. received in federal contracts?

Federal contracts obligated $254,426 to Harvard Bioscience Inc. in fiscal years 2023 through 2027.

What is Harvard Bioscience Inc.'s most recent federal award?

Harvard Bioscience Inc.'s most recent federal contract award is Definitive Contract 75N98026C00060, from Office of Logisitics and Acquisition Operations (NIH), on September 29, 2026.

On GovTribe

See Harvard Bioscience Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Federal grant awards
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors